▲◤◥◢▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰··················
◤◢◤◢◤◢
───────────────────────────────────────────────────────────
─
NSG 552
PSYCHOPHARMACOLOGY
EXAMS 1, 2 & 3
2026/2027 EDITION
───────────────────────────────────────────────────────────
─
Complete Accurate Exam Questions with Rationales | Graded A+
◆◇◆
◆ ◆ ◆ AUTHENTICATED TESTING RESOURCE ◆ ◆ ◆
, NSG 552 PSYCHOPHARMACOLOGY EXAMS 1, 2 & 3 | 2026/2027
Section 1: Brief Introduction
NSG 552 Advanced Psychopharmacology Comprehensive Examination Review (2026/2027
Edition) delivers an exhaustive, curricular-aligned 300-question testing assessment covering
foundational to advanced psychiatric prescribing competencies across Exams 1, 2, and 3. Exam
1 focuses on neurobiology, pharmacokinetics, pharmacodynamics, CYP450 metabolism,
pharmacogenomics, antidepressants, anxiolytics, and sedative-hypnotics; Exam 2 covers mood
stabilizers, first-/second-/third-generation antipsychotics, extrapyramidal symptoms, tardive
dyskinesia, neuroleptic malignant syndrome, and clozapine REMS protocols; and Exam 3
details ADHD psychostimulants, substance use disorder pharmacotherapies, special
populations (perinatal, pediatric, geriatric Beers Criteria), and treatment-resistant
augmentation strategies. Each examination features balanced answer distributions, high-yield
clinical vignettes, and thorough rationales reflecting current FDA-approved labeling and
evidence-based PMHNP guidelines.
Page | Complete Accurate Exam Questions with Rationales
, NSG 552 PSYCHOPHARMACOLOGY EXAMS 1, 2 & 3 | 2026/2027
Section 2: Exam 1 Questions (1–100)
1. A 32-year-old female with Major Depressive Disorder is initiated on fluoxetine 20 mg
daily. The PMHNP explains that fluoxetine selectively inhibits the serotonin transporter
(SERT). What acute downstream effect occurs at the presynaptic 5-HT1A somatodendritic
autoreceptors before clinical antidepressant efficacy is observed at 2 to 4 weeks?
A. Direct and irreversible blockade of postsynaptic 5-HT2A receptors resulting in
instant clinical remission
B. Rapid depletion of vesicular monoamine transporter 2 (VMAT2) stores in the raphe
nuclei
C. Immediate upregulation and hypersensitization of somatodendritic 5-HT1A
autoreceptors causing continuous rapid serotonin discharge
D. Acute somatodendritic 5-HT1A autoreceptor activation initially shuts down
presynaptic serotonin firing until the autoreceptors desensitize and
downregulate over several weeks
Rationale: When SERT is acutely blocked by an SSRI, serotonin builds up around presynaptic
somatodendritic 5-HT1A autoreceptors in the midbrain raphe nuclei, triggering an autoinhibitory
negative feedback loop that temporarily shuts down neuronal serotonin firing; after 2 to 4 weeks
of sustained agonism, these autoreceptors desensitize and downregulate, disinhibiting the neuron
and allowing sustained serotonin release at axon terminals.
2. Which cytochrome P450 isoenzyme is primarily responsible for the biotransformation of
approximately 25% of all clinically prescribed psychotropic medications, including most
tricyclic antidepressants, venlafaxine, atomoxetine, and several antipsychotics (e.g.,
risperidone, aripiprazole), and exhibits significant genetic polymorphism ranging from
poor to ultrarapid metabolizers?
A. CYP2E1
B. CYP3A4
C. CYP2D6
D. CYP1A2
Rationale: CYP2D6 is a high-affinity, low-capacity hepatic enzyme responsible for metabolizing
approximately 25% of all psychotropic drugs (including TCAs, atomoxetine, venlafaxine,
duloxetine, risperidone, aripiprazole, and codeine); it is non-inducible and highly polymorphic,
with genetically defined phenotypes including poor metabolizers (elevated drug levels/toxicity
risk) and ultrarapid metabolizers (subtherapeutic failure).
3. A 45-year-old male maintained on duloxetine 60 mg daily for depression begins taking
over-the-counter cimetidine and is prescribed ciprofloxacin for a bacterial urinary tract
Page | Complete Accurate Exam Questions with Rationales
, NSG 552 PSYCHOPHARMACOLOGY EXAMS 1, 2 & 3 | 2026/2027
infection. Both ciprofloxacin and fluvoxamine are potent inhibitors of which major
cytochrome P450 enzyme that metabolizes duloxetine, clozapine, and olanzapine?
A. CYP2C19
B. CYP1A2
C. CYP3A4
D. CYP2D6
Rationale: CYP1A2 is the primary metabolic clearance pathway for clozapine, olanzapine,
duloxetine, and theophylline; potent CYP1A2 inhibitors such as fluvoxamine and ciprofloxacin
dramatically increase plasma concentrations of these substrates (e.g., fluvoxamine can increase
clozapine levels 5- to 10-fold), predisposing patients to profound toxicity.
4. A patient with Treatment-Resistant Depression undergoes pharmacogenomic testing,
which reveals that the patient is a CYP2C19 'Poor Metabolizer' (*2/*2 genotype). When
considering SSRI pharmacotherapy, which medication requires a 50% dose reduction
(maximum daily dose of 20 mg in general adults) to prevent excessive serum drug
accumulation and dose-dependent QTc prolongation?
A. Citalopram
B. Venlafaxine
C. Fluoxetine
D. Paroxetine
Rationale: Citalopram (and its S-enantiomer escitalopram) is predominantly metabolized by
CYP2C19; individuals who are CYP2C19 poor metabolizers exhibit significantly reduced clearance
and elevated area-under-the-curve (AUC) plasma levels, requiring an FDA-mandated dosage cap
of 20 mg/day for citalopram to mitigate the risk of concentration-dependent QTc prolongation
and Torsades de Pointes.
5. Which pharmacokinetic concept defines the time required for the systemic plasma
concentration of a psychotropic drug to decrease by 50%, and dictates that approximately
4 to 5 elimination cycles are required to achieve steady-state plasma concentrations as well
as complete clearance upon discontinuation?
A. Elimination half-life (t1/2)
B. Therapeutic index (TI)
C. Bioavailability (F)
D. Volume of distribution (Vd)
Rationale: The elimination half-life (t1/2) is the time required for the plasma concentration of a
drug to decrease by half; based on first-order linear kinetics, reaching steady-state plasma
concentration upon initiating continuous dosing, as well as complete drug elimination (>95%
clearance) upon cessation, requires 4 to 5 elimination half-lives.
Page | Complete Accurate Exam Questions with Rationales
◤◢◤◢◤◢
───────────────────────────────────────────────────────────
─
NSG 552
PSYCHOPHARMACOLOGY
EXAMS 1, 2 & 3
2026/2027 EDITION
───────────────────────────────────────────────────────────
─
Complete Accurate Exam Questions with Rationales | Graded A+
◆◇◆
◆ ◆ ◆ AUTHENTICATED TESTING RESOURCE ◆ ◆ ◆
, NSG 552 PSYCHOPHARMACOLOGY EXAMS 1, 2 & 3 | 2026/2027
Section 1: Brief Introduction
NSG 552 Advanced Psychopharmacology Comprehensive Examination Review (2026/2027
Edition) delivers an exhaustive, curricular-aligned 300-question testing assessment covering
foundational to advanced psychiatric prescribing competencies across Exams 1, 2, and 3. Exam
1 focuses on neurobiology, pharmacokinetics, pharmacodynamics, CYP450 metabolism,
pharmacogenomics, antidepressants, anxiolytics, and sedative-hypnotics; Exam 2 covers mood
stabilizers, first-/second-/third-generation antipsychotics, extrapyramidal symptoms, tardive
dyskinesia, neuroleptic malignant syndrome, and clozapine REMS protocols; and Exam 3
details ADHD psychostimulants, substance use disorder pharmacotherapies, special
populations (perinatal, pediatric, geriatric Beers Criteria), and treatment-resistant
augmentation strategies. Each examination features balanced answer distributions, high-yield
clinical vignettes, and thorough rationales reflecting current FDA-approved labeling and
evidence-based PMHNP guidelines.
Page | Complete Accurate Exam Questions with Rationales
, NSG 552 PSYCHOPHARMACOLOGY EXAMS 1, 2 & 3 | 2026/2027
Section 2: Exam 1 Questions (1–100)
1. A 32-year-old female with Major Depressive Disorder is initiated on fluoxetine 20 mg
daily. The PMHNP explains that fluoxetine selectively inhibits the serotonin transporter
(SERT). What acute downstream effect occurs at the presynaptic 5-HT1A somatodendritic
autoreceptors before clinical antidepressant efficacy is observed at 2 to 4 weeks?
A. Direct and irreversible blockade of postsynaptic 5-HT2A receptors resulting in
instant clinical remission
B. Rapid depletion of vesicular monoamine transporter 2 (VMAT2) stores in the raphe
nuclei
C. Immediate upregulation and hypersensitization of somatodendritic 5-HT1A
autoreceptors causing continuous rapid serotonin discharge
D. Acute somatodendritic 5-HT1A autoreceptor activation initially shuts down
presynaptic serotonin firing until the autoreceptors desensitize and
downregulate over several weeks
Rationale: When SERT is acutely blocked by an SSRI, serotonin builds up around presynaptic
somatodendritic 5-HT1A autoreceptors in the midbrain raphe nuclei, triggering an autoinhibitory
negative feedback loop that temporarily shuts down neuronal serotonin firing; after 2 to 4 weeks
of sustained agonism, these autoreceptors desensitize and downregulate, disinhibiting the neuron
and allowing sustained serotonin release at axon terminals.
2. Which cytochrome P450 isoenzyme is primarily responsible for the biotransformation of
approximately 25% of all clinically prescribed psychotropic medications, including most
tricyclic antidepressants, venlafaxine, atomoxetine, and several antipsychotics (e.g.,
risperidone, aripiprazole), and exhibits significant genetic polymorphism ranging from
poor to ultrarapid metabolizers?
A. CYP2E1
B. CYP3A4
C. CYP2D6
D. CYP1A2
Rationale: CYP2D6 is a high-affinity, low-capacity hepatic enzyme responsible for metabolizing
approximately 25% of all psychotropic drugs (including TCAs, atomoxetine, venlafaxine,
duloxetine, risperidone, aripiprazole, and codeine); it is non-inducible and highly polymorphic,
with genetically defined phenotypes including poor metabolizers (elevated drug levels/toxicity
risk) and ultrarapid metabolizers (subtherapeutic failure).
3. A 45-year-old male maintained on duloxetine 60 mg daily for depression begins taking
over-the-counter cimetidine and is prescribed ciprofloxacin for a bacterial urinary tract
Page | Complete Accurate Exam Questions with Rationales
, NSG 552 PSYCHOPHARMACOLOGY EXAMS 1, 2 & 3 | 2026/2027
infection. Both ciprofloxacin and fluvoxamine are potent inhibitors of which major
cytochrome P450 enzyme that metabolizes duloxetine, clozapine, and olanzapine?
A. CYP2C19
B. CYP1A2
C. CYP3A4
D. CYP2D6
Rationale: CYP1A2 is the primary metabolic clearance pathway for clozapine, olanzapine,
duloxetine, and theophylline; potent CYP1A2 inhibitors such as fluvoxamine and ciprofloxacin
dramatically increase plasma concentrations of these substrates (e.g., fluvoxamine can increase
clozapine levels 5- to 10-fold), predisposing patients to profound toxicity.
4. A patient with Treatment-Resistant Depression undergoes pharmacogenomic testing,
which reveals that the patient is a CYP2C19 'Poor Metabolizer' (*2/*2 genotype). When
considering SSRI pharmacotherapy, which medication requires a 50% dose reduction
(maximum daily dose of 20 mg in general adults) to prevent excessive serum drug
accumulation and dose-dependent QTc prolongation?
A. Citalopram
B. Venlafaxine
C. Fluoxetine
D. Paroxetine
Rationale: Citalopram (and its S-enantiomer escitalopram) is predominantly metabolized by
CYP2C19; individuals who are CYP2C19 poor metabolizers exhibit significantly reduced clearance
and elevated area-under-the-curve (AUC) plasma levels, requiring an FDA-mandated dosage cap
of 20 mg/day for citalopram to mitigate the risk of concentration-dependent QTc prolongation
and Torsades de Pointes.
5. Which pharmacokinetic concept defines the time required for the systemic plasma
concentration of a psychotropic drug to decrease by 50%, and dictates that approximately
4 to 5 elimination cycles are required to achieve steady-state plasma concentrations as well
as complete clearance upon discontinuation?
A. Elimination half-life (t1/2)
B. Therapeutic index (TI)
C. Bioavailability (F)
D. Volume of distribution (Vd)
Rationale: The elimination half-life (t1/2) is the time required for the plasma concentration of a
drug to decrease by half; based on first-order linear kinetics, reaching steady-state plasma
concentration upon initiating continuous dosing, as well as complete drug elimination (>95%
clearance) upon cessation, requires 4 to 5 elimination half-lives.
Page | Complete Accurate Exam Questions with Rationales
